Skip to main content
Premium Trial:

Request an Annual Quote

Geneart Posts 16 Percent Revenue Growth for Q3

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geneart today reported third-quarter revenue growth of 16 percent and a sharp increase in its profit.

The German synthetic genomics firm reported revenues of €5 million ($6.9 million) for the quarter compared to €4.3 million for the third quarter of 2009.

Its earnings before interest and taxes was €135,000, up sharply from €25,000 for Q3 2009.

Geneart said that its operational performance "remained largely unaffected" by its takeover by Life Technologies' subsidiary Applied Biosystems Deutschland. The deal, which took place in May, provided Life Technologies with a 74 percent stake in Geneart for roughly €38 million.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.